"
Safety and Efficacy of a Novel Everolimus-Eluting Stent System in “Real-World” Patients with Coronary Artery Disease: A Report of Preliminary Outcomes"
written by Sridhar Kasturi, Srinivas Polasa, Shailender Singh, Vijay Kumar Reddy, Kondal Rao, Ganesh Mathan, Shiva Kumar Bandimida, Manikandhar Pendyala, Chandrashekar Challa,
published by
World Journal of Cardiovascular Diseases,
Vol.6 No.12, 2016
has been cited by the following article(s):
[1]
|
Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
Indian Heart Journal,
2023
DOI:10.1016/j.ihj.2023.03.006
|
|
|
[2]
|
Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
Indian Heart Journal,
2023
DOI:10.1016/j.ihj.2023.03.006
|
|
|
[3]
|
Ultrathin, biodegradable polymer-coated everolimus-eluting stents for patients undergoing percutaneous coronary intervention: Final three-year results of the PERFORM-EVER registry
Indian Heart Journal,
2023
DOI:10.1016/j.ihj.2023.10.009
|
|
|
[4]
|
Serial evaluation of vascular responses after implantation of everolimus‐eluting coronary stent by optical coherence tomography
Catheterization and Cardiovascular Interventions,
2022
DOI:10.1002/ccd.29794
|
|
|
[5]
|
Interventional Cardiology
2022
DOI:10.1002/9781119697367.ch36
|
|
|
[6]
|
Safety and performance of everolimus-eluting stents comprising of biodegradable polymers with ultrathin stent platforms
Minerva Medica,
2020
DOI:10.23736/S0026-4806.20.06205-9
|
|
|